Furiex Pharmaceuticals: Here’s What Investors Need to Know Before Earnings

Furiex Pharmaceuticals (NASDAQ:FURX) will report earnings after markets close on Tuesday, May 7th. Furiex Pharmaceuticals Inc. is a drug development company. The company partners with pharmaceutical and biotechnology companies and has a diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and a product on the market.

Here is your Cheat Sheet to Furiex Pharmaceuticals Earnings:

Earnings Expectations: Analysts expect earnings of $0.79 per share on revenues of $33.42 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $1.07 to a loss $1.14. For the current year, the average estimate is a loss of $1.63, which is better than the estimate ninety days ago.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

Earnings Trends:

Here’s how Furiex Pharmaceuticals has been performing on an annual basis:

Fiscal Year 2009 2010 2011 2012
Revenue ($) in millions 6.31 8.98 4.49 40.51
Diluted EPS ($) -0.90 -5.53 -4.96 -4.29

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 1.99 2.65 13.08 15.58 9.21
Diluted EPS ($) -0.6794 -0.98 -2.09 -0.33 -0.9039

Past Performance:
Furiex Pharmaceuticals has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)